WaveMan · Form 4
Carr Edward insider trades
> Search tickers & screens ⌘K
LIVE

Carr Edward insider trades

Carr Edward has filed 8 Form 4s with the SEC that we hold, for Dianthus Therapeutics, Inc. /DE/ (DNTH) (CHIEF ACCOUNTING OFFICER) and Abeona Therapeutics INC. (ABEO) (Chief Financial Officer). Across all of them we count 0 purchases worth $0 and 11 sales worth $5.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 10 sales ($5.6M). The largest single trade was a sale of 23,465 shares of Dianthus Therapeutics, Inc. /DE/ worth $1.9M, dated 2026-03-12. Of 5 sales filed since we began reading the 10b5-1 checkbox, 5 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-12 and the latest 2026-09-18.

Dianthus Therapeutics, Inc. /DE/ (DNTH)

CHIEF ACCOUNTING OFFICER · 6 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-03-12S, sale reported on Form 415,852$1.3M2026-03-13
2026-03-12S, sale reported on Form 4300$25.7K2026-03-13
2026-03-12S, sale reported on Form 4200$16.7K2026-03-13
2026-03-12S, sale reported on Form 43,865$319.5K2026-03-13
2026-03-12S, sale reported on Form 423,465$1.9M2026-03-13
2026-09-17S, sale reported on Form 47,928$796.2K2026-09-18
2026-09-17S, sale reported on Form 46,771$686.4K2026-09-18
2026-09-17S, sale reported on Form 43,501$358.5K2026-09-18
2026-09-17S, sale reported on Form 41,100$113.5K2026-09-18
2026-09-17S, sale reported on Form 4700$73.1K2026-09-18

Abeona Therapeutics INC. (ABEO)

Chief Financial Officer · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-10-08S, sale reported on Form 429,122$30.6K2021-10-08
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1273351) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms